nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—HTR6—Raloxifene—osteoporosis	0.123	0.199	CbGbCtD
Clomipramine—HTR2B—Raloxifene—osteoporosis	0.11	0.177	CbGbCtD
Clomipramine—ALB—Estropipate—osteoporosis	0.0653	0.105	CbGbCtD
Clomipramine—CYP1A2—Estropipate—osteoporosis	0.0391	0.063	CbGbCtD
Clomipramine—ALB—Estradiol—osteoporosis	0.0271	0.0437	CbGbCtD
Clomipramine—ABCB1—Ethinyl Estradiol—osteoporosis	0.022	0.0355	CbGbCtD
Clomipramine—CYP2C19—Cholecalciferol—osteoporosis	0.0218	0.0352	CbGbCtD
Clomipramine—CYP3A4—Estropipate—osteoporosis	0.0205	0.033	CbGbCtD
Clomipramine—CYP3A4—Calcitriol—osteoporosis	0.0205	0.033	CbGbCtD
Clomipramine—CYP1A2—Conjugated Estrogens—osteoporosis	0.0185	0.0298	CbGbCtD
Clomipramine—CYP2C19—Estradiol—osteoporosis	0.0176	0.0283	CbGbCtD
Clomipramine—CYP2D6—Cholecalciferol—osteoporosis	0.0166	0.0267	CbGbCtD
Clomipramine—CYP3A4—Ergocalciferol—osteoporosis	0.0164	0.0264	CbGbCtD
Clomipramine—CYP1A2—Estradiol—osteoporosis	0.0162	0.0261	CbGbCtD
Clomipramine—ABCB1—Conjugated Estrogens—osteoporosis	0.0162	0.026	CbGbCtD
Clomipramine—ABCB1—Estradiol—osteoporosis	0.0142	0.0229	CbGbCtD
Clomipramine—CYP3A4—Raloxifene—osteoporosis	0.0137	0.022	CbGbCtD
Clomipramine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0132	0.0213	CbGbCtD
Clomipramine—CYP3A4—Cholecalciferol—osteoporosis	0.0105	0.017	CbGbCtD
Clomipramine—CYP3A4—Conjugated Estrogens—osteoporosis	0.00968	0.0156	CbGbCtD
Clomipramine—CYP3A4—Estradiol—osteoporosis	0.0085	0.0137	CbGbCtD
Clomipramine—Hypotension—Pamidronate—osteoporosis	0.000119	0.000391	CcSEcCtD
Clomipramine—Convulsion—Conjugated Estrogens—osteoporosis	0.000119	0.000391	CcSEcCtD
Clomipramine—Dry mouth—Zoledronate—osteoporosis	0.000119	0.00039	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000119	0.00039	CcSEcCtD
Clomipramine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000119	0.000389	CcSEcCtD
Clomipramine—Pruritus—Alendronate—osteoporosis	0.000118	0.000388	CcSEcCtD
Clomipramine—Dyspepsia—Risedronate—osteoporosis	0.000118	0.000387	CcSEcCtD
Clomipramine—Eye disorder—Estradiol—osteoporosis	0.000118	0.000387	CcSEcCtD
Clomipramine—Tinnitus—Estradiol—osteoporosis	0.000118	0.000386	CcSEcCtD
Clomipramine—Constipation—Ethinyl Estradiol—osteoporosis	0.000118	0.000386	CcSEcCtD
Clomipramine—Confusional state—Zoledronate—osteoporosis	0.000117	0.000385	CcSEcCtD
Clomipramine—Hypersensitivity—Calcitriol—osteoporosis	0.000117	0.000385	CcSEcCtD
Clomipramine—Flushing—Estradiol—osteoporosis	0.000117	0.000385	CcSEcCtD
Clomipramine—Cardiac disorder—Estradiol—osteoporosis	0.000117	0.000385	CcSEcCtD
Clomipramine—Chest pain—Conjugated Estrogens—osteoporosis	0.000117	0.000384	CcSEcCtD
Clomipramine—Myalgia—Conjugated Estrogens—osteoporosis	0.000117	0.000384	CcSEcCtD
Clomipramine—Arthralgia—Conjugated Estrogens—osteoporosis	0.000117	0.000384	CcSEcCtD
Clomipramine—Asthenia—Ibandronate—osteoporosis	0.000117	0.000383	CcSEcCtD
Clomipramine—Anxiety—Conjugated Estrogens—osteoporosis	0.000117	0.000382	CcSEcCtD
Clomipramine—Nausea—Etidronic acid—osteoporosis	0.000117	0.000382	CcSEcCtD
Clomipramine—Anaphylactic shock—Zoledronate—osteoporosis	0.000116	0.000382	CcSEcCtD
Clomipramine—Oedema—Zoledronate—osteoporosis	0.000116	0.000382	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000116	0.000381	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000116	0.000381	CcSEcCtD
Clomipramine—Diarrhoea—Estropipate—osteoporosis	0.000116	0.000381	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000116	0.00038	CcSEcCtD
Clomipramine—Fatigue—Risedronate—osteoporosis	0.000116	0.000379	CcSEcCtD
Clomipramine—Insomnia—Pamidronate—osteoporosis	0.000115	0.000378	CcSEcCtD
Clomipramine—Pruritus—Ibandronate—osteoporosis	0.000115	0.000378	CcSEcCtD
Clomipramine—Pain—Risedronate—osteoporosis	0.000115	0.000376	CcSEcCtD
Clomipramine—Constipation—Risedronate—osteoporosis	0.000115	0.000376	CcSEcCtD
Clomipramine—Angiopathy—Estradiol—osteoporosis	0.000115	0.000376	CcSEcCtD
Clomipramine—Shock—Zoledronate—osteoporosis	0.000115	0.000376	CcSEcCtD
Clomipramine—Paraesthesia—Pamidronate—osteoporosis	0.000114	0.000376	CcSEcCtD
Clomipramine—Diarrhoea—Alendronate—osteoporosis	0.000114	0.000375	CcSEcCtD
Clomipramine—Asthenia—Calcitriol—osteoporosis	0.000114	0.000375	CcSEcCtD
Clomipramine—Nervous system disorder—Zoledronate—osteoporosis	0.000114	0.000375	CcSEcCtD
Clomipramine—Immune system disorder—Estradiol—osteoporosis	0.000114	0.000374	CcSEcCtD
Clomipramine—Thrombocytopenia—Zoledronate—osteoporosis	0.000114	0.000374	CcSEcCtD
Clomipramine—Mediastinal disorder—Estradiol—osteoporosis	0.000114	0.000374	CcSEcCtD
Clomipramine—Dyspnoea—Pamidronate—osteoporosis	0.000114	0.000373	CcSEcCtD
Clomipramine—Tachycardia—Zoledronate—osteoporosis	0.000114	0.000373	CcSEcCtD
Clomipramine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000113	0.000372	CcSEcCtD
Clomipramine—Chills—Estradiol—osteoporosis	0.000113	0.000372	CcSEcCtD
Clomipramine—Somnolence—Pamidronate—osteoporosis	0.000113	0.000372	CcSEcCtD
Clomipramine—Skin disorder—Zoledronate—osteoporosis	0.000113	0.000371	CcSEcCtD
Clomipramine—Pruritus—Calcitriol—osteoporosis	0.000113	0.00037	CcSEcCtD
Clomipramine—Hyperhidrosis—Zoledronate—osteoporosis	0.000113	0.000369	CcSEcCtD
Clomipramine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000112	0.000369	CcSEcCtD
Clomipramine—Diarrhoea—Raloxifene—osteoporosis	0.000112	0.000369	CcSEcCtD
Clomipramine—Dyspepsia—Pamidronate—osteoporosis	0.000112	0.000368	CcSEcCtD
Clomipramine—Dizziness—Estropipate—osteoporosis	0.000112	0.000368	CcSEcCtD
Clomipramine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000112	0.000368	CcSEcCtD
Clomipramine—Oedema—Conjugated Estrogens—osteoporosis	0.000112	0.000368	CcSEcCtD
Clomipramine—Alopecia—Estradiol—osteoporosis	0.000112	0.000366	CcSEcCtD
Clomipramine—Diarrhoea—Ibandronate—osteoporosis	0.000111	0.000365	CcSEcCtD
Clomipramine—Anorexia—Zoledronate—osteoporosis	0.000111	0.000364	CcSEcCtD
Clomipramine—Decreased appetite—Pamidronate—osteoporosis	0.000111	0.000364	CcSEcCtD
Clomipramine—Mental disorder—Estradiol—osteoporosis	0.000111	0.000363	CcSEcCtD
Clomipramine—Dizziness—Alendronate—osteoporosis	0.000111	0.000363	CcSEcCtD
Clomipramine—Shock—Conjugated Estrogens—osteoporosis	0.00011	0.000362	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00011	0.000361	CcSEcCtD
Clomipramine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00011	0.000361	CcSEcCtD
Clomipramine—Malnutrition—Estradiol—osteoporosis	0.00011	0.000361	CcSEcCtD
Clomipramine—Fatigue—Pamidronate—osteoporosis	0.00011	0.000361	CcSEcCtD
Clomipramine—Gastrointestinal pain—Risedronate—osteoporosis	0.00011	0.00036	CcSEcCtD
Clomipramine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000109	0.000359	CcSEcCtD
Clomipramine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000109	0.000359	CcSEcCtD
Clomipramine—Constipation—Pamidronate—osteoporosis	0.000109	0.000358	CcSEcCtD
Clomipramine—Pain—Pamidronate—osteoporosis	0.000109	0.000358	CcSEcCtD
Clomipramine—Diarrhoea—Calcitriol—osteoporosis	0.000109	0.000358	CcSEcCtD
Clomipramine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000109	0.000357	CcSEcCtD
Clomipramine—Hypotension—Zoledronate—osteoporosis	0.000109	0.000357	CcSEcCtD
Clomipramine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000109	0.000357	CcSEcCtD
Clomipramine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000109	0.000357	CcSEcCtD
Clomipramine—Dizziness—Raloxifene—osteoporosis	0.000109	0.000357	CcSEcCtD
Clomipramine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000108	0.000356	CcSEcCtD
Clomipramine—Flatulence—Estradiol—osteoporosis	0.000108	0.000356	CcSEcCtD
Clomipramine—Tension—Estradiol—osteoporosis	0.000108	0.000354	CcSEcCtD
Clomipramine—Vomiting—Estropipate—osteoporosis	0.000108	0.000354	CcSEcCtD
Clomipramine—Dysgeusia—Estradiol—osteoporosis	0.000108	0.000353	CcSEcCtD
Clomipramine—Dizziness—Ibandronate—osteoporosis	0.000108	0.000353	CcSEcCtD
Clomipramine—Rash—Estropipate—osteoporosis	0.000107	0.000351	CcSEcCtD
Clomipramine—Dermatitis—Estropipate—osteoporosis	0.000107	0.000351	CcSEcCtD
Clomipramine—Anorexia—Conjugated Estrogens—osteoporosis	0.000107	0.000351	CcSEcCtD
Clomipramine—Nervousness—Estradiol—osteoporosis	0.000107	0.00035	CcSEcCtD
Clomipramine—Urticaria—Risedronate—osteoporosis	0.000107	0.00035	CcSEcCtD
Clomipramine—Back pain—Estradiol—osteoporosis	0.000106	0.000349	CcSEcCtD
Clomipramine—Headache—Estropipate—osteoporosis	0.000106	0.000349	CcSEcCtD
Clomipramine—Vomiting—Alendronate—osteoporosis	0.000106	0.000349	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000106	0.000348	CcSEcCtD
Clomipramine—Body temperature increased—Risedronate—osteoporosis	0.000106	0.000348	CcSEcCtD
Clomipramine—Abdominal pain—Risedronate—osteoporosis	0.000106	0.000348	CcSEcCtD
Clomipramine—Muscle spasms—Estradiol—osteoporosis	0.000106	0.000347	CcSEcCtD
Clomipramine—Rash—Alendronate—osteoporosis	0.000105	0.000346	CcSEcCtD
Clomipramine—Insomnia—Zoledronate—osteoporosis	0.000105	0.000346	CcSEcCtD
Clomipramine—Dermatitis—Alendronate—osteoporosis	0.000105	0.000345	CcSEcCtD
Clomipramine—Feeling abnormal—Pamidronate—osteoporosis	0.000105	0.000345	CcSEcCtD
Clomipramine—Hypotension—Conjugated Estrogens—osteoporosis	0.000105	0.000344	CcSEcCtD
Clomipramine—Headache—Alendronate—osteoporosis	0.000105	0.000344	CcSEcCtD
Clomipramine—Paraesthesia—Zoledronate—osteoporosis	0.000105	0.000343	CcSEcCtD
Clomipramine—Vomiting—Raloxifene—osteoporosis	0.000105	0.000343	CcSEcCtD
Clomipramine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000104	0.000342	CcSEcCtD
Clomipramine—Dyspnoea—Zoledronate—osteoporosis	0.000104	0.000341	CcSEcCtD
Clomipramine—Rash—Raloxifene—osteoporosis	0.000104	0.00034	CcSEcCtD
Clomipramine—Dermatitis—Raloxifene—osteoporosis	0.000104	0.00034	CcSEcCtD
Clomipramine—Somnolence—Zoledronate—osteoporosis	0.000104	0.00034	CcSEcCtD
Clomipramine—Vomiting—Ibandronate—osteoporosis	0.000103	0.000339	CcSEcCtD
Clomipramine—Tremor—Estradiol—osteoporosis	0.000103	0.000338	CcSEcCtD
Clomipramine—Headache—Raloxifene—osteoporosis	0.000103	0.000338	CcSEcCtD
Clomipramine—Rash—Ibandronate—osteoporosis	0.000103	0.000337	CcSEcCtD
Clomipramine—Dermatitis—Ibandronate—osteoporosis	0.000102	0.000336	CcSEcCtD
Clomipramine—Dyspepsia—Zoledronate—osteoporosis	0.000102	0.000336	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000102	0.000335	CcSEcCtD
Clomipramine—Ill-defined disorder—Estradiol—osteoporosis	0.000102	0.000335	CcSEcCtD
Clomipramine—Headache—Ibandronate—osteoporosis	0.000102	0.000334	CcSEcCtD
Clomipramine—Insomnia—Conjugated Estrogens—osteoporosis	0.000101	0.000333	CcSEcCtD
Clomipramine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000101	0.000333	CcSEcCtD
Clomipramine—Vomiting—Calcitriol—osteoporosis	0.000101	0.000332	CcSEcCtD
Clomipramine—Decreased appetite—Zoledronate—osteoporosis	0.000101	0.000332	CcSEcCtD
Clomipramine—Agitation—Estradiol—osteoporosis	0.000101	0.000332	CcSEcCtD
Clomipramine—Nausea—Estropipate—osteoporosis	0.000101	0.000331	CcSEcCtD
Clomipramine—Body temperature increased—Pamidronate—osteoporosis	0.000101	0.000331	CcSEcCtD
Clomipramine—Abdominal pain—Pamidronate—osteoporosis	0.000101	0.000331	CcSEcCtD
Clomipramine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000101	0.00033	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000101	0.00033	CcSEcCtD
Clomipramine—Rash—Calcitriol—osteoporosis	0.0001	0.00033	CcSEcCtD
Clomipramine—Fatigue—Zoledronate—osteoporosis	0.0001	0.000329	CcSEcCtD
Clomipramine—Dermatitis—Calcitriol—osteoporosis	0.0001	0.000329	CcSEcCtD
Clomipramine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.0001	0.000328	CcSEcCtD
Clomipramine—Headache—Calcitriol—osteoporosis	9.98e-05	0.000327	CcSEcCtD
Clomipramine—Somnolence—Conjugated Estrogens—osteoporosis	9.97e-05	0.000327	CcSEcCtD
Clomipramine—Pain—Zoledronate—osteoporosis	9.96e-05	0.000327	CcSEcCtD
Clomipramine—Constipation—Zoledronate—osteoporosis	9.96e-05	0.000327	CcSEcCtD
Clomipramine—Nausea—Alendronate—osteoporosis	9.93e-05	0.000326	CcSEcCtD
Clomipramine—Malaise—Estradiol—osteoporosis	9.92e-05	0.000325	CcSEcCtD
Clomipramine—Hypersensitivity—Risedronate—osteoporosis	9.88e-05	0.000324	CcSEcCtD
Clomipramine—Vertigo—Estradiol—osteoporosis	9.88e-05	0.000324	CcSEcCtD
Clomipramine—Dyspepsia—Conjugated Estrogens—osteoporosis	9.87e-05	0.000324	CcSEcCtD
Clomipramine—Asthenia—Ethinyl Estradiol—osteoporosis	9.87e-05	0.000324	CcSEcCtD
Clomipramine—Syncope—Estradiol—osteoporosis	9.86e-05	0.000324	CcSEcCtD
Clomipramine—Nausea—Raloxifene—osteoporosis	9.76e-05	0.00032	CcSEcCtD
Clomipramine—Decreased appetite—Conjugated Estrogens—osteoporosis	9.75e-05	0.00032	CcSEcCtD
Clomipramine—Pruritus—Ethinyl Estradiol—osteoporosis	9.73e-05	0.000319	CcSEcCtD
Clomipramine—Palpitations—Estradiol—osteoporosis	9.72e-05	0.000319	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	9.68e-05	0.000318	CcSEcCtD
Clomipramine—Fatigue—Conjugated Estrogens—osteoporosis	9.67e-05	0.000317	CcSEcCtD
Clomipramine—Nausea—Ibandronate—osteoporosis	9.67e-05	0.000317	CcSEcCtD
Clomipramine—Loss of consciousness—Estradiol—osteoporosis	9.66e-05	0.000317	CcSEcCtD
Clomipramine—Asthenia—Risedronate—osteoporosis	9.62e-05	0.000316	CcSEcCtD
Clomipramine—Feeling abnormal—Zoledronate—osteoporosis	9.6e-05	0.000315	CcSEcCtD
Clomipramine—Cough—Estradiol—osteoporosis	9.59e-05	0.000315	CcSEcCtD
Clomipramine—Pain—Conjugated Estrogens—osteoporosis	9.59e-05	0.000315	CcSEcCtD
Clomipramine—Constipation—Conjugated Estrogens—osteoporosis	9.59e-05	0.000315	CcSEcCtD
Clomipramine—Gastrointestinal pain—Zoledronate—osteoporosis	9.52e-05	0.000312	CcSEcCtD
Clomipramine—Hypertension—Estradiol—osteoporosis	9.49e-05	0.000311	CcSEcCtD
Clomipramine—Pruritus—Risedronate—osteoporosis	9.49e-05	0.000311	CcSEcCtD
Clomipramine—Nausea—Calcitriol—osteoporosis	9.46e-05	0.00031	CcSEcCtD
Clomipramine—Diarrhoea—Ethinyl Estradiol—osteoporosis	9.41e-05	0.000309	CcSEcCtD
Clomipramine—Hypersensitivity—Pamidronate—osteoporosis	9.39e-05	0.000308	CcSEcCtD
Clomipramine—Chest pain—Estradiol—osteoporosis	9.36e-05	0.000307	CcSEcCtD
Clomipramine—Arthralgia—Estradiol—osteoporosis	9.36e-05	0.000307	CcSEcCtD
Clomipramine—Myalgia—Estradiol—osteoporosis	9.36e-05	0.000307	CcSEcCtD
Clomipramine—Anxiety—Estradiol—osteoporosis	9.33e-05	0.000306	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	9.3e-05	0.000305	CcSEcCtD
Clomipramine—Urticaria—Zoledronate—osteoporosis	9.25e-05	0.000304	CcSEcCtD
Clomipramine—Discomfort—Estradiol—osteoporosis	9.25e-05	0.000303	CcSEcCtD
Clomipramine—Body temperature increased—Zoledronate—osteoporosis	9.2e-05	0.000302	CcSEcCtD
Clomipramine—Abdominal pain—Zoledronate—osteoporosis	9.2e-05	0.000302	CcSEcCtD
Clomipramine—Diarrhoea—Risedronate—osteoporosis	9.18e-05	0.000301	CcSEcCtD
Clomipramine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	9.17e-05	0.000301	CcSEcCtD
Clomipramine—Dry mouth—Estradiol—osteoporosis	9.15e-05	0.0003	CcSEcCtD
Clomipramine—Asthenia—Pamidronate—osteoporosis	9.15e-05	0.0003	CcSEcCtD
Clomipramine—Dizziness—Ethinyl Estradiol—osteoporosis	9.09e-05	0.000298	CcSEcCtD
Clomipramine—Confusional state—Estradiol—osteoporosis	9.05e-05	0.000297	CcSEcCtD
Clomipramine—Pruritus—Pamidronate—osteoporosis	9.02e-05	0.000296	CcSEcCtD
Clomipramine—Oedema—Estradiol—osteoporosis	8.97e-05	0.000294	CcSEcCtD
Clomipramine—Anaphylactic shock—Estradiol—osteoporosis	8.97e-05	0.000294	CcSEcCtD
Clomipramine—Urticaria—Conjugated Estrogens—osteoporosis	8.91e-05	0.000292	CcSEcCtD
Clomipramine—Dizziness—Risedronate—osteoporosis	8.87e-05	0.000291	CcSEcCtD
Clomipramine—Abdominal pain—Conjugated Estrogens—osteoporosis	8.86e-05	0.000291	CcSEcCtD
Clomipramine—Body temperature increased—Conjugated Estrogens—osteoporosis	8.86e-05	0.000291	CcSEcCtD
Clomipramine—Shock—Estradiol—osteoporosis	8.83e-05	0.00029	CcSEcCtD
Clomipramine—Nervous system disorder—Estradiol—osteoporosis	8.8e-05	0.000289	CcSEcCtD
Clomipramine—Tachycardia—Estradiol—osteoporosis	8.76e-05	0.000287	CcSEcCtD
Clomipramine—Vomiting—Ethinyl Estradiol—osteoporosis	8.74e-05	0.000287	CcSEcCtD
Clomipramine—Diarrhoea—Pamidronate—osteoporosis	8.72e-05	0.000286	CcSEcCtD
Clomipramine—Skin disorder—Estradiol—osteoporosis	8.72e-05	0.000286	CcSEcCtD
Clomipramine—Hyperhidrosis—Estradiol—osteoporosis	8.67e-05	0.000285	CcSEcCtD
Clomipramine—Rash—Ethinyl Estradiol—osteoporosis	8.67e-05	0.000285	CcSEcCtD
Clomipramine—Dermatitis—Ethinyl Estradiol—osteoporosis	8.66e-05	0.000284	CcSEcCtD
Clomipramine—Headache—Ethinyl Estradiol—osteoporosis	8.62e-05	0.000283	CcSEcCtD
Clomipramine—Hypersensitivity—Zoledronate—osteoporosis	8.58e-05	0.000282	CcSEcCtD
Clomipramine—Vomiting—Risedronate—osteoporosis	8.53e-05	0.00028	CcSEcCtD
Clomipramine—Rash—Risedronate—osteoporosis	8.46e-05	0.000277	CcSEcCtD
Clomipramine—Dermatitis—Risedronate—osteoporosis	8.45e-05	0.000277	CcSEcCtD
Clomipramine—Dizziness—Pamidronate—osteoporosis	8.43e-05	0.000277	CcSEcCtD
Clomipramine—Headache—Risedronate—osteoporosis	8.4e-05	0.000276	CcSEcCtD
Clomipramine—Asthenia—Zoledronate—osteoporosis	8.35e-05	0.000274	CcSEcCtD
Clomipramine—Hypersensitivity—Conjugated Estrogens—osteoporosis	8.26e-05	0.000271	CcSEcCtD
Clomipramine—Pruritus—Zoledronate—osteoporosis	8.24e-05	0.00027	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Estradiol—osteoporosis	8.18e-05	0.000268	CcSEcCtD
Clomipramine—Nausea—Ethinyl Estradiol—osteoporosis	8.17e-05	0.000268	CcSEcCtD
Clomipramine—Insomnia—Estradiol—osteoporosis	8.12e-05	0.000266	CcSEcCtD
Clomipramine—Vomiting—Pamidronate—osteoporosis	8.11e-05	0.000266	CcSEcCtD
Clomipramine—Paraesthesia—Estradiol—osteoporosis	8.06e-05	0.000264	CcSEcCtD
Clomipramine—Asthenia—Conjugated Estrogens—osteoporosis	8.04e-05	0.000264	CcSEcCtD
Clomipramine—Rash—Pamidronate—osteoporosis	8.04e-05	0.000264	CcSEcCtD
Clomipramine—Dermatitis—Pamidronate—osteoporosis	8.03e-05	0.000263	CcSEcCtD
Clomipramine—Dyspnoea—Estradiol—osteoporosis	8e-05	0.000263	CcSEcCtD
Clomipramine—Headache—Pamidronate—osteoporosis	7.99e-05	0.000262	CcSEcCtD
Clomipramine—Somnolence—Estradiol—osteoporosis	7.98e-05	0.000262	CcSEcCtD
Clomipramine—Diarrhoea—Zoledronate—osteoporosis	7.97e-05	0.000261	CcSEcCtD
Clomipramine—Nausea—Risedronate—osteoporosis	7.97e-05	0.000261	CcSEcCtD
Clomipramine—Pruritus—Conjugated Estrogens—osteoporosis	7.93e-05	0.00026	CcSEcCtD
Clomipramine—Dyspepsia—Estradiol—osteoporosis	7.9e-05	0.000259	CcSEcCtD
Clomipramine—Decreased appetite—Estradiol—osteoporosis	7.8e-05	0.000256	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Estradiol—osteoporosis	7.75e-05	0.000254	CcSEcCtD
Clomipramine—Fatigue—Estradiol—osteoporosis	7.74e-05	0.000254	CcSEcCtD
Clomipramine—Dizziness—Zoledronate—osteoporosis	7.7e-05	0.000253	CcSEcCtD
Clomipramine—Constipation—Estradiol—osteoporosis	7.67e-05	0.000252	CcSEcCtD
Clomipramine—Pain—Estradiol—osteoporosis	7.67e-05	0.000252	CcSEcCtD
Clomipramine—Diarrhoea—Conjugated Estrogens—osteoporosis	7.67e-05	0.000252	CcSEcCtD
Clomipramine—Nausea—Pamidronate—osteoporosis	7.57e-05	0.000248	CcSEcCtD
Clomipramine—Dizziness—Conjugated Estrogens—osteoporosis	7.41e-05	0.000243	CcSEcCtD
Clomipramine—Vomiting—Zoledronate—osteoporosis	7.4e-05	0.000243	CcSEcCtD
Clomipramine—Feeling abnormal—Estradiol—osteoporosis	7.39e-05	0.000243	CcSEcCtD
Clomipramine—Rash—Zoledronate—osteoporosis	7.34e-05	0.000241	CcSEcCtD
Clomipramine—Gastrointestinal pain—Estradiol—osteoporosis	7.34e-05	0.000241	CcSEcCtD
Clomipramine—Dermatitis—Zoledronate—osteoporosis	7.33e-05	0.000241	CcSEcCtD
Clomipramine—Headache—Zoledronate—osteoporosis	7.29e-05	0.000239	CcSEcCtD
Clomipramine—Vomiting—Conjugated Estrogens—osteoporosis	7.13e-05	0.000234	CcSEcCtD
Clomipramine—Urticaria—Estradiol—osteoporosis	7.13e-05	0.000234	CcSEcCtD
Clomipramine—Body temperature increased—Estradiol—osteoporosis	7.09e-05	0.000233	CcSEcCtD
Clomipramine—Abdominal pain—Estradiol—osteoporosis	7.09e-05	0.000233	CcSEcCtD
Clomipramine—Rash—Conjugated Estrogens—osteoporosis	7.07e-05	0.000232	CcSEcCtD
Clomipramine—Dermatitis—Conjugated Estrogens—osteoporosis	7.06e-05	0.000232	CcSEcCtD
Clomipramine—Headache—Conjugated Estrogens—osteoporosis	7.02e-05	0.00023	CcSEcCtD
Clomipramine—Nausea—Zoledronate—osteoporosis	6.92e-05	0.000227	CcSEcCtD
Clomipramine—Nausea—Conjugated Estrogens—osteoporosis	6.66e-05	0.000219	CcSEcCtD
Clomipramine—Hypersensitivity—Estradiol—osteoporosis	6.61e-05	0.000217	CcSEcCtD
Clomipramine—Asthenia—Estradiol—osteoporosis	6.44e-05	0.000211	CcSEcCtD
Clomipramine—Pruritus—Estradiol—osteoporosis	6.35e-05	0.000208	CcSEcCtD
Clomipramine—Diarrhoea—Estradiol—osteoporosis	6.14e-05	0.000201	CcSEcCtD
Clomipramine—Dizziness—Estradiol—osteoporosis	5.93e-05	0.000195	CcSEcCtD
Clomipramine—Vomiting—Estradiol—osteoporosis	5.71e-05	0.000187	CcSEcCtD
Clomipramine—Rash—Estradiol—osteoporosis	5.66e-05	0.000186	CcSEcCtD
Clomipramine—Dermatitis—Estradiol—osteoporosis	5.65e-05	0.000185	CcSEcCtD
Clomipramine—Headache—Estradiol—osteoporosis	5.62e-05	0.000184	CcSEcCtD
Clomipramine—Nausea—Estradiol—osteoporosis	5.33e-05	0.000175	CcSEcCtD
Clomipramine—ADRA2A—Hemostasis—IGF1—osteoporosis	2.01e-05	0.000269	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—RAP1A—osteoporosis	2e-05	0.000268	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—FDPS—osteoporosis	1.99e-05	0.000266	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PKM—osteoporosis	1.99e-05	0.000266	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CNR2—osteoporosis	1.99e-05	0.000266	CbGpPWpGaD
Clomipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	1.98e-05	0.000265	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—IDH2—osteoporosis	1.97e-05	0.000264	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—ADCY5—osteoporosis	1.97e-05	0.000264	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NFATC1—osteoporosis	1.96e-05	0.000262	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PTHLH—osteoporosis	1.95e-05	0.00026	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—BMP2—osteoporosis	1.95e-05	0.00026	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.94e-05	0.00026	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—DKK1—osteoporosis	1.94e-05	0.00026	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—KL—osteoporosis	1.93e-05	0.000258	CbGpPWpGaD
Clomipramine—ALB—Metabolism—TPI1—osteoporosis	1.91e-05	0.000256	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—P4HB—osteoporosis	1.91e-05	0.000255	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—FGB—osteoporosis	1.9e-05	0.000255	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—OXCT1—osteoporosis	1.9e-05	0.000254	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CA2—osteoporosis	1.9e-05	0.000254	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CYP27A1—osteoporosis	1.9e-05	0.000254	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IRS2—osteoporosis	1.89e-05	0.000253	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GPD2—osteoporosis	1.89e-05	0.000253	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PGLS—osteoporosis	1.89e-05	0.000253	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—POMC—osteoporosis	1.88e-05	0.000252	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—WNT1—osteoporosis	1.87e-05	0.00025	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—IDH2—osteoporosis	1.86e-05	0.000249	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PTH—osteoporosis	1.86e-05	0.000248	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CYP27A1—osteoporosis	1.86e-05	0.000248	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—MGLL—osteoporosis	1.85e-05	0.000248	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ACP5—osteoporosis	1.85e-05	0.000247	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—LEP—osteoporosis	1.85e-05	0.000247	CbGpPWpGaD
Clomipramine—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	1.84e-05	0.000247	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PSMA2—osteoporosis	1.84e-05	0.000246	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PSMA5—osteoporosis	1.84e-05	0.000246	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—IL6R—osteoporosis	1.83e-05	0.000246	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.83e-05	0.000244	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—RAP1A—osteoporosis	1.82e-05	0.000244	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.82e-05	0.000244	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—FGA—osteoporosis	1.82e-05	0.000243	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.82e-05	0.000243	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CNR2—osteoporosis	1.81e-05	0.000242	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ACP5—osteoporosis	1.8e-05	0.000242	CbGpPWpGaD
Clomipramine—ALB—Metabolism—P4HB—osteoporosis	1.8e-05	0.000241	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—ADCY5—osteoporosis	1.79e-05	0.00024	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—ADCY5—osteoporosis	1.79e-05	0.00024	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NFATC1—osteoporosis	1.78e-05	0.000238	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GAPDH—osteoporosis	1.77e-05	0.000237	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—DKK1—osteoporosis	1.76e-05	0.000236	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—ESR1—osteoporosis	1.76e-05	0.000236	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—ENO1—osteoporosis	1.76e-05	0.000236	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.75e-05	0.000234	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.75e-05	0.000234	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PSMA5—osteoporosis	1.74e-05	0.000233	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PSMA2—osteoporosis	1.74e-05	0.000233	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ATIC—osteoporosis	1.73e-05	0.000231	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PNP—osteoporosis	1.73e-05	0.000231	CbGpPWpGaD
Clomipramine—ALB—Metabolism—RAP1A—osteoporosis	1.72e-05	0.00023	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—TPI1—osteoporosis	1.72e-05	0.00023	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CALCA—osteoporosis	1.71e-05	0.000229	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ACP5—osteoporosis	1.7e-05	0.000228	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—WNT1—osteoporosis	1.7e-05	0.000228	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.7e-05	0.000228	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.7e-05	0.000227	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PTHLH—osteoporosis	1.69e-05	0.000226	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—BMP2—osteoporosis	1.69e-05	0.000226	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—TPI1—osteoporosis	1.68e-05	0.000225	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—POMC—osteoporosis	1.67e-05	0.000224	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—ADCY5—osteoporosis	1.65e-05	0.000222	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—FGB—osteoporosis	1.65e-05	0.000221	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—FGA—osteoporosis	1.65e-05	0.000221	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IRS1—osteoporosis	1.65e-05	0.000221	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—ADCY5—osteoporosis	1.63e-05	0.000218	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—P4HB—osteoporosis	1.62e-05	0.000216	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—SPP1—osteoporosis	1.6e-05	0.000214	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PSMA2—osteoporosis	1.6e-05	0.000214	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PSMA5—osteoporosis	1.6e-05	0.000214	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—POMC—osteoporosis	1.59e-05	0.000212	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GAPDH—osteoporosis	1.59e-05	0.000212	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—IGF1—osteoporosis	1.59e-05	0.000212	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—TPI1—osteoporosis	1.58e-05	0.000212	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—P4HB—osteoporosis	1.58e-05	0.000211	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—IDH2—osteoporosis	1.58e-05	0.000211	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—KL—osteoporosis	1.56e-05	0.000208	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GAPDH—osteoporosis	1.55e-05	0.000207	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IL6R—osteoporosis	1.55e-05	0.000207	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—RAP1A—osteoporosis	1.55e-05	0.000207	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PTHLH—osteoporosis	1.54e-05	0.000206	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—BMP2—osteoporosis	1.54e-05	0.000206	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IGF1—osteoporosis	1.53e-05	0.000204	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—POMC—osteoporosis	1.52e-05	0.000203	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—ADCY5—osteoporosis	1.51e-05	0.000202	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—RAP1A—osteoporosis	1.51e-05	0.000202	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—FGB—osteoporosis	1.5e-05	0.000201	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.5e-05	0.000201	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CALCA—osteoporosis	1.49e-05	0.000199	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—P4HB—osteoporosis	1.49e-05	0.000199	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.48e-05	0.000198	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—IL6R—osteoporosis	1.48e-05	0.000198	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CA2—osteoporosis	1.47e-05	0.000196	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—OXCT1—osteoporosis	1.47e-05	0.000196	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—SPP1—osteoporosis	1.46e-05	0.000196	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GAPDH—osteoporosis	1.46e-05	0.000195	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PSMA2—osteoporosis	1.45e-05	0.000194	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PSMA5—osteoporosis	1.45e-05	0.000194	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—POMC—osteoporosis	1.45e-05	0.000194	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IRS2—osteoporosis	1.45e-05	0.000194	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ACP5—osteoporosis	1.44e-05	0.000193	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—MGLL—osteoporosis	1.43e-05	0.000191	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.42e-05	0.00019	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—RAP1A—osteoporosis	1.42e-05	0.00019	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—LEP—osteoporosis	1.42e-05	0.00019	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CYP19A1—osteoporosis	1.41e-05	0.000189	CbGpPWpGaD
Clomipramine—ALB—Metabolism—ENO1—osteoporosis	1.39e-05	0.000186	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PSMA5—osteoporosis	1.37e-05	0.000184	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PSMA2—osteoporosis	1.37e-05	0.000184	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CALCA—osteoporosis	1.35e-05	0.000181	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—ESR1—osteoporosis	1.35e-05	0.000181	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—KL—osteoporosis	1.35e-05	0.000181	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.35e-05	0.00018	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—TPI1—osteoporosis	1.34e-05	0.000179	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IRS2—osteoporosis	1.32e-05	0.000177	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	1.32e-05	0.000177	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—POMC—osteoporosis	1.32e-05	0.000176	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—LEP—osteoporosis	1.29e-05	0.000173	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—IL6R—osteoporosis	1.29e-05	0.000172	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IRS1—osteoporosis	1.26e-05	0.000169	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—P4HB—osteoporosis	1.26e-05	0.000169	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ENO1—osteoporosis	1.25e-05	0.000167	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GAPDH—osteoporosis	1.24e-05	0.000165	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—ESR1—osteoporosis	1.23e-05	0.000165	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PSMA5—osteoporosis	1.23e-05	0.000165	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PSMA2—osteoporosis	1.23e-05	0.000165	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—KL—osteoporosis	1.23e-05	0.000165	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ENO1—osteoporosis	1.22e-05	0.000163	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—ADCY5—osteoporosis	1.22e-05	0.000163	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—POMC—osteoporosis	1.22e-05	0.000163	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—IDH2—osteoporosis	1.22e-05	0.000163	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—TGFB1—osteoporosis	1.2e-05	0.000161	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—RAP1A—osteoporosis	1.2e-05	0.000161	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PSMA2—osteoporosis	1.2e-05	0.000161	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PSMA5—osteoporosis	1.2e-05	0.000161	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—POMC—osteoporosis	1.2e-05	0.00016	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IL6R—osteoporosis	1.19e-05	0.000159	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—SPP1—osteoporosis	1.18e-05	0.000158	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IGF1—osteoporosis	1.17e-05	0.000157	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	1.17e-05	0.000157	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—IL6—osteoporosis	1.17e-05	0.000156	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IRS1—osteoporosis	1.15e-05	0.000154	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—ADCY5—osteoporosis	1.15e-05	0.000154	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ENO1—osteoporosis	1.15e-05	0.000154	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—GPX1—osteoporosis	1.15e-05	0.000154	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.14e-05	0.000153	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PSMA2—osteoporosis	1.13e-05	0.000152	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PSMA5—osteoporosis	1.13e-05	0.000152	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CYP19A1—osteoporosis	1.11e-05	0.000149	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ACP5—osteoporosis	1.11e-05	0.000149	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—POMC—osteoporosis	1.11e-05	0.000149	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IL6R—osteoporosis	1.08e-05	0.000145	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IGF1—osteoporosis	1.07e-05	0.000143	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IRS2—osteoporosis	1.07e-05	0.000143	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—MTHFR—osteoporosis	1.06e-05	0.000142	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—ADCY5—osteoporosis	1.06e-05	0.000142	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.05e-05	0.000141	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—LEP—osteoporosis	1.04e-05	0.00014	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—TPI1—osteoporosis	1.03e-05	0.000138	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SPP1—osteoporosis	1.02e-05	0.000137	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CYP19A1—osteoporosis	9.98e-06	0.000134	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—ESR1—osteoporosis	9.96e-06	0.000133	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CYP19A1—osteoporosis	9.75e-06	0.00013	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ENO1—osteoporosis	9.73e-06	0.00013	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—P4HB—osteoporosis	9.72e-06	0.00013	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	9.63e-06	0.000129	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PSMA2—osteoporosis	9.59e-06	0.000128	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PSMA5—osteoporosis	9.59e-06	0.000128	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GAPDH—osteoporosis	9.54e-06	0.000128	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—TGFB1—osteoporosis	9.51e-06	0.000127	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SPP1—osteoporosis	9.32e-06	0.000125	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IRS1—osteoporosis	9.31e-06	0.000125	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—RAP1A—osteoporosis	9.29e-06	0.000124	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IRS2—osteoporosis	9.26e-06	0.000124	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CYP19A1—osteoporosis	9.18e-06	0.000123	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—MYC—osteoporosis	9.17e-06	0.000123	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TGFB1—osteoporosis	9.15e-06	0.000123	CbGpPWpGaD
Clomipramine—ALB—Metabolism—ADCY5—osteoporosis	9.09e-06	0.000122	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—LEP—osteoporosis	9.06e-06	0.000121	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GPX1—osteoporosis	9.06e-06	0.000121	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—POMC—osteoporosis	8.96e-06	0.00012	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—IL6—osteoporosis	8.95e-06	0.00012	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL6R—osteoporosis	8.74e-06	0.000117	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—ESR1—osteoporosis	8.65e-06	0.000116	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IGF1—osteoporosis	8.62e-06	0.000115	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—POMC—osteoporosis	8.47e-06	0.000113	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IRS2—osteoporosis	8.42e-06	0.000113	CbGpPWpGaD
Clomipramine—ALB—Metabolism—MTHFR—osteoporosis	8.36e-06	0.000112	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—LEP—osteoporosis	8.24e-06	0.00011	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—IL6—osteoporosis	8.17e-06	0.000109	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ADCY5—osteoporosis	8.16e-06	0.000109	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GPX1—osteoporosis	8.13e-06	0.000109	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IRS1—osteoporosis	8.08e-06	0.000108	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ADCY5—osteoporosis	7.96e-06	0.000107	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GPX1—osteoporosis	7.94e-06	0.000106	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ESR1—osteoporosis	7.87e-06	0.000105	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—POMC—osteoporosis	7.78e-06	0.000104	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CYP19A1—osteoporosis	7.78e-06	0.000104	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL6R—osteoporosis	7.59e-06	0.000102	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ENO1—osteoporosis	7.51e-06	0.000101	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ADCY5—osteoporosis	7.5e-06	0.0001	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—MTHFR—osteoporosis	7.5e-06	0.0001	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IGF1—osteoporosis	7.49e-06	0.0001	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GPX1—osteoporosis	7.48e-06	0.0001	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PSMA5—osteoporosis	7.4e-06	9.91e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PSMA2—osteoporosis	7.4e-06	9.91e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IRS1—osteoporosis	7.35e-06	9.84e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—MTHFR—osteoporosis	7.32e-06	9.8e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—POMC—osteoporosis	7.08e-06	9.48e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MYC—osteoporosis	7.04e-06	9.42e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TGFB1—osteoporosis	7.02e-06	9.4e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL6R—osteoporosis	6.91e-06	9.25e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—MTHFR—osteoporosis	6.9e-06	9.24e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IL6—osteoporosis	6.9e-06	9.23e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IGF1—osteoporosis	6.81e-06	9.12e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—POMC—osteoporosis	6.68e-06	8.95e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—IL6—osteoporosis	6.59e-06	8.83e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MYC—osteoporosis	6.42e-06	8.6e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TGFB1—osteoporosis	6.41e-06	8.58e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ADCY5—osteoporosis	6.36e-06	8.51e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GPX1—osteoporosis	6.33e-06	8.48e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP19A1—osteoporosis	6e-06	8.04e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—POMC—osteoporosis	6e-06	8.03e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—POMC—osteoporosis	5.86e-06	7.84e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—MTHFR—osteoporosis	5.85e-06	7.83e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—IL6—osteoporosis	5.73e-06	7.66e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—POMC—osteoporosis	5.52e-06	7.39e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IL6—osteoporosis	5.29e-06	7.08e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—IL6—osteoporosis	5.21e-06	6.97e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MYC—osteoporosis	5.18e-06	6.94e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TGFB1—osteoporosis	5.17e-06	6.92e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ADCY5—osteoporosis	4.91e-06	6.57e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GPX1—osteoporosis	4.89e-06	6.54e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IL6—osteoporosis	4.83e-06	6.46e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—POMC—osteoporosis	4.68e-06	6.26e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—MTHFR—osteoporosis	4.51e-06	6.04e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MYC—osteoporosis	4.5e-06	6.02e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TGFB1—osteoporosis	4.49e-06	6.01e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MYC—osteoporosis	4.09e-06	5.48e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	4.08e-06	5.47e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL6—osteoporosis	3.9e-06	5.21e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—POMC—osteoporosis	3.61e-06	4.83e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL6—osteoporosis	3.38e-06	4.53e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL6—osteoporosis	3.08e-06	4.12e-05	CbGpPWpGaD
